Imaging of focal liver lesions: The 90 %-rule;Bildgebende Diagnostik fokaler Leberläsionen: Die 90 %-Regel

Ultraschall in der Medizin

Volumn 31, Issue 6, 2010, Pages 545-547

  Mostbeck, G ^a  

^a WILHELMINEN HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ANGIOGRAPHY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EDITORIAL; HUMAN; IMAGE PROCESSING; LIVER; LIVER DISEASE; LIVER TUMOR; METASTASIS; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ANGIOGRAPHY; CONTRAST MEDIA; FOCAL NODULAR HYPERPLASIA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 78649829378     PISSN: 01724614     EISSN: 14388782     Source Type: Journal    
DOI: 10.1055/s-0029-1245839     Document Type: Review

References (20)

1. Buraggi G L., Laurini R, Rodari A et al. Double-tracer scintigraphy with 67Ga-citrate and 99mTc-sulfur colloid in the diagnosis of hepatic tumors. Journal of Nuclear Medicine 1976 17 369-373
2. Engel M A., Marks D S., Sandler M A. et al. Differentiation of focal intrahepatic lesions with 99mTc-red blood cell imaging. Rad 1983 146 777-782
3. Koenigsberg M, Friedman L. Multinuclide evaluation of hepatic mass lesions. Crit Rev Radiol Nucl Med 1975 6 113-152
4. Sugarbaker P H., Vermess M, Doppmann J L. et al. Improved detection of focal lesions with computerized tomographic examination of the liver using ethiodized oil emulsion (EOE-13) liver contrast. Cancer 1984 54 1489-1495
5. Urban B A., Fishman E K., Kuhlman J E. et al. Detection of focal hepatic lesions with spiral CT: Comparison of 4- and 8-mm interscan spacing. AJR 1993 160 783-785
6. Heiken J P., Weyman P J., Lee J KT et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Rad 1989 171 47-51
7. Kondo H, Kanematsu M, Hoshi H et al. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. AJR 2000 174 947-954
8. Semelka R C., Shoenut J P., Kroeker M A. et al. Focal liver lesions: comparison of dynamic contrast-enhanced CT and T 2-weighted fat-suppressed, FLASH, and dynamic Gadolinium-enhanced MR imaging at 1.5 T. Rad 1992 184 687-694
9. Senterre E, Taourel P, Bouvier Y et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Rad 1996 200 785-792
10. Heilmaier C, Lutz A M., Bolog N et al. Focal liver lesions: detection and characterization at double-contrast liver MR imaging with ferucarbotan and gadubotrol versus single-contrast liver MR imaging. Rad 2009 253 724-733
11. Petersein J, Spinazzi A, Giovagnoni A et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging a multicenter phase III clinical study. Rad 2000 215 727-736
12. Parikh T, Drew S J., Lee V S. et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T 2-weighted imaging. Rad 2008 246 812-822
13. Lechmann-Riemen R van, Illiger H J. Oberbauchsonografie Screeninguntersuchung in der Tumorambulanz. Ultraschall in Med 1982 3 294-297
14. Seemann M D., Bonl H, Wintersperger B et al. Vergleich eines High-End-Ultraschallgerätes mit einem Spiral-CT-Scanner beim Screening von Lebermetastasen. Ultraschall in Med 1998 19 164-167
15. Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR 2009 193 86-95
16. Strobel D, Seitz K, Blank W et al. Contrast-enhanced Ultrasound for the Characterization of Focal Liver lesions Diagnostic Accuracy in Clinical Practice. Ultraschall in Med 2008 29 499-505
17. Bernatik T, Blank W, Schuler A et al. Unclear focal liver lesions in contrast-enhanced ultrasonography lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Ultraschall in Med 2010 31 577-581
18. Ladam-Marcus V, Mac G, Job L et al. Performance de lchographie de contraste en pathologie hpatique: synthse de la literature. JRadiol 2009 90 93-108
19. Leen E, Goldberg J A., Anderson J R. et al. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut 1993 34 554-557
20. Haendl T, Strobel D, Neureiter D et al. Vergleich der hepatischen Transitzeit (HTT) verschiedener Ultraschallkontrastmittel (USKM) bei Patienten mit Lebermetastasen und gesunden Probanden. Ultraschall in Med 2010 31 582-588